Table 6

Clinical and economic effects of the vaccination programme
Results Year Five-year results
1 2 3 4 5
Base scenario
 Avoided hospitalized pneumonias 1,134 5,755 13,078 21,471 29,998 71,436
 Avoided outpatient pneumonias 762 3,869 8,792 14,434 20,166 48,022
 Avoided primary bacteremias 31 156 313 572 686 1,758
 Avoided empyemas 0 2 4 8 9 24
 Avoided meningitis 10 51 103 189 226 579
 Avoided bacteremic pneumonias 71 363 728 1,330 1,594 4,087
Avoided contagions 2,008 10,196 23,018 38,004 52,680 125,906
 Hospitalized pneumonia cost savings 2,247,819 11,411,544 25,933,983 42,577,699 59,486,125 141,657,169
 Outpatient pneumonia cost savings 190,504 967,134 2,197,917 3,608,480 5,041,478 12,005,513
 Primary bacteremias cost savings 125,824 639,232 1,281,675 2,341,411 2,807,267 7,195,409
 Empyemas cost savings 2,486 12,628 25,319 46,254 55,457 142,145
 Meningitis cost savings 113,513 576,685 1,156,266 2,112,310 2,532,584 6,491,358
 Bacteremic pneumonias cost savings 387,336 1,967,803 3,945,487 7,207,762 8,641,848 22,150,236
Savings by all cases averted 3,067,481 15,575,025 34,540,648 57,893,917 78,564,759 189,641,830
 Cost of vaccinations 15,197,172 15,197,172 15,197,172 15,197,172 15,197,172 75,985,862
 Net healthcare cost 12,129,691 −377,853 −19,343,475 −42,696,744 −63,367,587 −113,655,968
Discounted net healthcare cost 12,129,691 −366,848 −18,233,081 −39,073,569 −56,301,280 −101,845,087

Pradas et al.

Pradas et al. BMC Infectious Diseases 2013 13:175   doi:10.1186/1471-2334-13-175

Open Data